COVID-19 studies for: C19 studies:  HC QHC Q Vitamin DVitamin D IvermectinIVM LY-CoVLY REGN-COV2REGN RemdesivirRMD
HC Q study #121
Source   PDF   Share   Tweet
See all 143 studies
Late treatment study
Heberto et al., IJC Heart & Vasculature, doi:10.1016/j.ijcha.2020.100638 (Peer Reviewed)
Implications of myocardial injury in Mexican hospitalized patients with coronavirus disease 2019 (COVID-19)
Observational prospective 254 hospitalized patients, HC Q+AZ mortality odds ratio OR 0.36, p = 0.04.
Ventilation OR 0.20, p = 0.008.
death, ↓53.6%, p=0.04
ventilation, ↓65.6%, p=0.008
(odds ratio converted to relative risk)
Source   PDF   Share   Tweet
See all 143 studies
Please send us corrections, updates, or comments.